Lenzapro Flex Patch
Product Images NDC 70512-013

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lenzapro Flex (NDC 70512-013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sola Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Lenzapro Flex (Lenzapro Patch2 Copy)

Lenzapro Flex (Lenzapro Patch2 Copy)
This is a description of a topical pain patch that uses improved Flex Patch Technology to temporarily relieve pain. It contains Lidocaine HCI 4% and Menthol 4% as active ingredients. The patch should not be applied to wounds, damaged, broken or irritated skin or used with other topical analgesics. The directions instruct adults and children over 12 years to clean and dry the affected area, remove one patch from the pouch and apply it to the affected area. The patch should be used for up to 12 hours, and it should not be used for more than one week without consulting a doctor. The patch should be disposed of in a manner that keeps the product away from children and pets. The pouch should be resealed after each use, and the product should be protected from direct sunlight and excessive moisture. Contact with eyes and mucous membranes should be avoided. The item is manufactured in the USA and comes in a resealable pouch containing 15 patches.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.